Wiretapping and Legal Ethics, and More from CRS
New reports from the Congressional Research Service that have not been released to the public include the following.
Wiretapping, Tape Recorders, and Legal Ethics: An Overview of Questions Posed by Attorney Involvement in Secretly Recording Conversation, August 9, 2012
The Speech or Debate Clause: Constitutional Background and Recent Developments, August 8, 2012
FY2013 National Defense Authorization Act: Selected Military Personnel Policy Issues, August 9, 2012
Major Fiscal Issues Before Congress in FY2013, August 10, 2012
FY2013 Appropriations: District of Columbia, August 10, 2012
Newly updated editions of earlier CRS reports that Congress has also not made readily available to the public include these:
Navy Irregular Warfare and Counterterrorism Operations: Background and Issues for Congress, August 10, 2012
Navy Aegis Ballistic Missile Defense (BMD) Program: Background and Issues for Congress, August 10, 2012
Navy Littoral Combat Ship (LCS) Program: Background, Issues and Options for Congress, August 10, 2012
Navy Nuclear Aircraft Carrier (CVN) Homeporting at Mayport: Background and Issues for Congress, August 10, 2012
Navy Shipboard Lasers for Surface, Air, and Missile Defense: Background and Issues for Congress, August 10, 2012
Navy DDG-51 and DDG-1000 Destroyer Programs: Background and Issues for Congress, August 10, 2012
Budget “Sequestration” and Selected Program Exemptions and Special Rules, August 9, 2012
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.